Literature DB >> 22302680

Estrogen suppresses expression of the matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs (RECK) within the mouse uterus.

Xuan Zhang1, Caitlin Healy, Warren B Nothnick.   

Abstract

RECK (reversion-inducing cysteine-rich protein with Kazal motifs) is a membrane-anchored glycoprotein which regulates MMP2 and MMP9 activity and has been proposed to play a role in embryo implantation while misexpression of RECK has been associated with a variety of carcinomas. Unfortunately, understanding on the steroidal regulation of uterine RECK is lacking. To address this gap in our knowledge, we examined steroidal regulation and cellular expression of Reck mRNA and protein within the mouse uterus in vivo. Uterine Reck mRNA and protein were decreased by estrogen, while progesterone alone had no effect. The estrogen-induced down regulation could be partially blocked by progesterone. RECK was localized primarily to luminal and glandular epithelial cells and the level of expression was regulated in a similar fashion as in whole tissue by the steroids. Knock-down of endogenous RECK in human endometrial epithelial and stromal cells resulted in a significant increase in active MMP9 expression but not that of pro-MMP9 or MMP2. These studies demonstrate that RECK expression in the mouse uterus is steroidally regulated and that within endometrial epithelial and stromal cells, RECK regulates MMP9, but not MMP2 activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302680     DOI: 10.1007/s12020-012-9614-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  62 in total

1.  Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis.

Authors:  J Szamatowicz; P Laudański; I Tomaszewska
Journal:  Hum Reprod       Date:  2002-02       Impact factor: 6.918

2.  Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer.

Authors:  Michel F P van der Jagt; Fred C G J Sweep; Erwin T Waas; Thijs Hendriks; Theo J M Ruers; Audrey H H Merry; Theo Wobbes; Paul N Span
Journal:  Cancer Lett       Date:  2005-07-19       Impact factor: 8.679

3.  Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis.

Authors:  T Collette; R Maheux; J Mailloux; A Akoum
Journal:  Hum Reprod       Date:  2006-07-31       Impact factor: 6.918

4.  Steroidal regulation of uterine miRNAs is associated with modulation of the miRNA biogenesis components Exportin-5 and Dicer1.

Authors:  Warren B Nothnick; Caitlin Healy; Xiaoman Hong
Journal:  Endocrine       Date:  2010-04       Impact factor: 3.633

5.  RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs.

Authors:  K Furumoto; S Arii; A Mori; H Furuyama; M J Gorrin Rivas; T Nakao; N Isobe; T Murata; C Takahashi; M Noda; M Imamura
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

6.  Molecular cloning of canine membrane-anchored inhibitor of matrix metalloproteinase, RECK.

Authors:  Satoshi Takagi; Takanori Kitamura; Yoshinao Hosaka; Tomohiro Ohsaki; Darko Bosnakovski; Tsuyoshi Kadosawa; Masahiro Okumura; Toru Fujinaga
Journal:  J Vet Med Sci       Date:  2005-04       Impact factor: 1.267

7.  Expression of matrix metalloproteinases-2 and -9 and RECK during alveolar bone regeneration in rat.

Authors:  Thais Accorsi-Mendonça; Katiúcia Batista da Silva Paiva; Willian Fernando Zambuzzi; Tânia Mary Cestari; Vanessa Soares Lara; Mari Cleide Sogayar; Rumio Taga; José Mauro Granjeiro
Journal:  J Mol Histol       Date:  2007-11-07       Impact factor: 2.611

8.  The possible mechanism of enhanced carcinogenesis induced by genotoxic carcinogens in rasH2 mice.

Authors:  Miwa Okamura; Akira Unami; Mitsuyoshi Moto; Masako Muguruma; Tadashi Ito; Meilan Jin; Yuji Oishi; Yoko Kashida; Kunitoshi Mitsumori
Journal:  Cancer Lett       Date:  2006-03-13       Impact factor: 8.679

9.  Estrogen-induced uterine abnormalities in TIMP-1 deficient mice are associated with elevated plasmin activity and reduced expression of the novel uterine plasmin protease inhibitor serpinb7.

Authors:  Xuan Zhang; Etter Hoang; Warren B Nothnick
Journal:  Mol Reprod Dev       Date:  2009-02       Impact factor: 2.609

10.  Induction of tissue inhibitor of metalloproteinase 3 gene expression during in vitro decidualization of human endometrial stromal cells.

Authors:  T Higuchi; H Kanzaki; H Nakayama; M Fujimoto; H Hatayama; K Kojima; M Iwai; T Mori; J Fujita
Journal:  Endocrinology       Date:  1995-11       Impact factor: 4.736

View more
  4 in total

Review 1.  Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: The RECKlessness of adverse remodeling.

Authors:  Jacob J Russell; Laurel A Grisanti; Scott M Brown; Chastidy A Bailey; Shawn B Bender; B Chandrasekar
Journal:  Cell Signal       Date:  2021-03-27       Impact factor: 4.850

2.  Effects of Di-(2-ethylhexyl) Phthalate on the Hypothalamus-Uterus in Pubertal Female Rats.

Authors:  Te Liu; Yiyang Jia; Liting Zhou; Qi Wang; Di Sun; Jin Xu; Juan Wu; Huaiji Chen; Feng Xu; Lin Ye
Journal:  Int J Environ Res Public Health       Date:  2016-11-12       Impact factor: 3.390

3.  Spatio-temporal expression profile of matrix metalloproteinase (Mmp) modulators Reck and Sparc during the rat ovarian dynamics.

Authors:  Gabriel Levin; Tatiane Maldonado Coelho; Nathali Guimarães Nóbrega; Marina Trombetta-Lima; Mari Cleide Sogayar; Ana Claudia Oliveira Carreira
Journal:  Reprod Biol Endocrinol       Date:  2018-11-13       Impact factor: 5.211

4.  Estrogens Regulate Placental Angiogenesis in Horses.

Authors:  Shingo Haneda; Pouya Dini; Alejandro Esteller-Vico; Kirsten E Scoggin; Edward L Squires; Mats H Troedsson; Peter Daels; Yasuo Nambo; Barry A Ball
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.